
1. sci adv. 2019 sep 4;5(9):eaaw0109. doi: 10.1126/sciadv.aaw0109. ecollection 2019 
sep.

the ferroportin q248h mutation protects anemia, malaria or
bacteremia.

muriuki jm(1), mentzer aj(2), band g(2), gilchrist jj(2)(3), carstensen t(4),
lule sa(5)(6), goheen mm(7)(8), joof f(7), kimita w(1), mogire r(1), cutland
cl(9), diarra a(10), rautanen a(2), pomilla c(4), gurdasani d(4), rockett k(2),
mturi n(1), ndungu fm(1), scott jag(1)(6), sirima sb(10), morovat a(11), prentice
am(7), madhi sa(9), webb el(6), elliott am(5)(6), bejon p(1)(12), sandhu ms(4),
hill avs(2)(13), kwiatkowski dp(2)(4), williams tn(1)(12)(14), cerami c(7),
atkinson sh(1)(3)(12).

author information: 
(1)kenya medical research institute (kemri) wellcome trust research programme,
kilifi, kenya.
(2)wellcome centre human genetics, nuffield department medicine,
university oxford, oxford, uk.
(3)department paediatrics, university oxford, oxford, uk.
(4)wellcome sanger institute, hinxton, cambridge, uk.
(5)medical research council/uganda virus research institute london school 
hygiene & tropical medicine uganda research unit, entebbe, uganda.
(6)london school hygiene tropical medicine, london, uk.
(7)medical research council unit gambia london school hygiene and
tropical medicine, banjul, gambia.
(8)university north carolina school medicine, cb 7435, chapel hill, north
carolina usa.
(9)medical research council: respiratory meningeal pathogens research unit,
faculty health sciences, university witwatersrand, johannesburg, south 
africa.
(10)centre de recherche action en sante (gras), 06 bp 10248, ouagadougou 06,
burkina faso.
(11)department clinical biochemistry, oxford university hospitals, oxford, uk.
(12)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk.
(13)centre clinical vaccinology tropical medicine jenner
institute laboratories, university oxford, oxford, uk.
(14)department medicine, imperial college, london, uk.

iron acquisition critical life. ferroportin (fpn) exports iron mature
erythrocytes, deletion fpn gene results hemolytic anemia and
increased fatality malaria-infected mice. fpn q248h mutation (glutamine to
histidine position 248) renders fpn partially resistant hepcidin-induced
degradation associated protection malaria human studies of
limited size. using data cohorts including 18,000 african children, 
show q248h mutation associated modest protection anemia,
hemolysis, iron deficiency, found little evidence protection
against severe malaria bacteremia. additionally observed excess
plasmodium growth q248h erythrocytes ex vivo, evidence selection driven
by malaria exposure, suggesting q248h mutation protect from
malaria unlikely deprive malaria parasites iron essential 
growth.

doi: 10.1126/sciadv.aaw0109 
pmcid: pmc6726445
pmid: 31517041  [indexed medline]

